Cargando…

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies

Effective therapeutic vaccines contain two primary constituents, antigen and adjuvant. Adjuvants consisting of microbial pattern molecules play a central role in vaccination. Successful vaccine requires efficient induction of antibody (Ab), type I interferons (IFN), cytokines/chemokines, cytotoxic T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seya, Tsukasa, Akazawa, Takashi, Tsujita, Tadayuki, Matsumoto, Misako
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2006
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1375233/ https://www.ncbi.nlm.nih.gov/pubmed/16550221 http://dx.doi.org/10.1093/ecam/nek010

Ejemplares similares

Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity
por: Seya, Tsukasa, et al.
Publicado: (2015)

Pan-Vertebrate Toll-Like Receptors During Evolution
por: Oshiumi, Hiroyuki, et al.
Publicado: (2008)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
por: Matsumoto, Misako, et al.
Publicado: (2017)

Role of TOLL-like Receptors in Adjuvant-Augmented Immune Therapies by T. Seya
por: Cooper, Edwin L.
Publicado: (2006)

Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model
por: Yoshida, Sumito, et al.
Publicado: (2018)

Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement
por: Seya, Tsukasa, et al.
Publicado: (2022)

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
por: Shime, Hiroaki, et al.
Publicado: (2017)

Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
por: Iwakiri, Dai, et al.
Publicado: (2009)

Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination
por: Seya, Tsukasa, et al.
Publicado: (2023)

Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
por: Yoshida, Sumito, et al.
Publicado: (2019)

A Distinct Role of Riplet-Mediated K63-Linked Polyubiquitination of the RIG-I Repressor Domain in Human Antiviral Innate Immune Responses
por: Oshiumi, Hiroyuki, et al.
Publicado: (2013)

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy
por: SEYA, Tsukasa, et al.
Publicado: (2018)

The Anti-Oxidant Ergothioneine Augments the Immunomodulatory Function of TLR Agonists by Direct Action on Macrophages
por: Yoshida, Sumito, et al.
Publicado: (2017)

An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma
por: Ehira, Nobuyuki, et al.
Publicado: (2010)

Correction: an embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma
por: Ehira, Nobuyuki, et al.
Publicado: (2014)

TAMable tumor-associated macrophages in response to innate RNA sensing
por: Seya, Tsukasa, et al.
Publicado: (2012)

Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
por: Toussi, Deana N., et al.
Publicado: (2014)

Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells
por: Azuma, Masahiro, et al.
Publicado: (2012)

Nucleic Acid Sensors Involved in the Recognition of HBV in the Liver–Specific in vivo Transfection Mouse Models—Pattern Recognition Receptors and Sensors for HBV
por: Leong, Chean Ring, et al.
Publicado: (2015)

Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy
por: Takeda, Yohei, et al.
Publicado: (2016)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma
por: Brueseke, Taylor J, et al.
Publicado: (2013)

TLR2-Dependent Induction of IL-10 and Foxp3(+)CD25(+)CD4(+) Regulatory T Cells Prevents Effective Anti-Tumor Immunity Induced by Pam2 Lipopeptides In Vivo
por: Yamazaki, Sayuri, et al.
Publicado: (2011)

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
por: Cen, Xiaohong, et al.
Publicado: (2018)

Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV)
por: Nakai, Masato, et al.
Publicado: (2015)

The dataset of proteins specifically interacted with activated TICAM-1
por: Funami, Kenji, et al.
Publicado: (2016)

Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models
por: Takeda, Yohei, et al.
Publicado: (2018)

Innate immunity and Toll-like receptors
por: O'Neill, LAJ
Publicado: (2004)

Role of Toll-Like Receptors in Immune Activation and Tolerance in the Liver
por: Nakamoto, Nobuhiro, et al.
Publicado: (2014)

The role of Toll‐like receptor 10 in modulation of trained immunity
por: Mourits, Vera P., et al.
Publicado: (2019)

A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier
por: Xie, Daping, et al.
Publicado: (2022)

The Role of Toll Like Receptors in Pregnancy
por: Amirchaghmaghi, Elham, et al.
Publicado: (2013)

The Role of Toll-Like Receptors in Oncotherapy
por: Liu, Caiqi, et al.
Publicado: (2019)

The Role of Toll-Like Receptors in Osteoclastogenesis
por: Yim, Mijung
Publicado: (2020)

Activation of Toll-like receptor 7/8 encoded by the X chromosome alters sperm motility and provides a novel simple technology for sexing sperm
por: Umehara, Takashi, et al.
Publicado: (2019)

TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
por: Seya, Tsukasa, et al.
Publicado: (2012)

Dendritic Cells from Oral Cavity Induce Foxp3(+) Regulatory T Cells upon Antigen Stimulation
por: Yamazaki, Sayuri, et al.
Publicado: (2012)

Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide
por: Takeda, Yohei, et al.
Publicado: (2018)

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
por: Martins, Karen A. O., et al.
Publicado: (2014)

The role of Toll-like receptor-4 in pertussis vaccine-induced immunity
por: Banus, Sander, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4jo2e649gongta6o8o707lr5m1